Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 13;9(8):510.
doi: 10.3390/antibiotics9080510.

The Ascidian-Derived Metabolites with Antimicrobial Properties

Affiliations
Review

The Ascidian-Derived Metabolites with Antimicrobial Properties

Marcello Casertano et al. Antibiotics (Basel). .

Abstract

Among the sub-phylum of Tunicate, ascidians represent the most abundant class of marine invertebrates, with 3000 species by heterogeneous habitat, that is, from shallow water to deep sea, already reported. The chemistry of these sessile filter-feeding organisms is an attractive reservoir of varied and peculiar bioactive compounds. Most secondary metabolites isolated from ascidians stand out for their potential as putative therapeutic agents in the treatment of several illnesses like microbial infections. In this review, we present and discuss the antibacterial activity shown by the main groups of ascidian-derived products, such as sulfur-containing compounds, meroterpenes, alkaloids, peptides, furanones, and their derivatives. Moreover, the direct evidence of a symbiotic association between marine ascidians and microorganisms shed light on the real producers of many extremely potent marine natural compounds. Hence, we also report the antibacterial potential, joined to antifungal and antiviral activity, of metabolites isolated from ascidian-associate microorganisms by culture-dependent methods.

Keywords: antibacterial; antimicrobial; antiviral; ascidian; ascidian-associated microorganisms; marine natural products.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(A) Percentage distribution of microorganisms paired to ascidians from which marine metabolites derive; (B) bioactivities of secondary metabolites isolated from ascidian-associated microorganisms described as percentage distribution.
Figure 2
Figure 2
Structures of the antimicrobial polysulfides lissoclinotoxins (12), varacins (36), and namenamicin (7).
Figure 3
Figure 3
Structures of alkyl and alkenyl sulfates 811.
Figure 4
Figure 4
Structures of the geranylhydroquinone derivatives 1216 and of rossinones (1721).
Figure 5
Figure 5
Structures of the amino alcohols crucigasterins (2226), pseudoaminols (2733), (2S, 3R)-2-aminododecan-3-ol (34), and distaminolyne A (35).
Figure 6
Figure 6
Structures of didemnaketals D–G (3639).
Figure 7
Figure 7
Structures of the peptide-like compounds halocyamines (40 and 41), and of rodriguesines A and B (42 and 43).
Figure 8
Figure 8
Structures of the β-carbolines alkaloids eudistomins (4466), 7-Bromo-N-hydroxyhomotrypargine (67), and didemnolines A–D (6871).
Figure 9
Figure 9
Structures of the pyridoacridine alkaloids 7288.
Figure 10
Figure 10
Structures of the indolizine alkaloids piclavines (8991).
Figure 11
Figure 11
Structures of the guanidine alkaloids tubastrine (92), 3-dehydroxy tubastrine (93), and synoxazolidinones A–C (9496).
Figure 12
Figure 12
Structures of the furanone derivatives rubrolides A–H, J, P, and Q (97111) and cadiolides B–N (112124).
Figure 13
Figure 13
Structures of synoilides A (125) and B (126) and isocadiolides A–H (127134).
Figure 14
Figure 14
Structures of compounds 135145 derived from ascidian-associated actinobacteria.
Figure 15
Figure 15
Structures of compounds 146157 derived from ascidian-associated fungi.
Figure 16
Figure 16
Structures of the cyanobacteria-derived bisanthraquinones 1 and 2 (158 and 159).

References

    1. Furusawa C., Horinouchi T., Maeda T. Toward Prediction and Control of Antibiotic-Resistance Evolution. Curr. Opin. Biotechnol. 2018;54:45–49. doi: 10.1016/j.copbio.2018.01.026. - DOI - PubMed
    1. WHO No Time to Wait: Securing the Future from Drug-Resistant Infections. [(accessed on 30 April 2019)];2019 Apr; Available online: https://www.who.int/antimicrobial-resistance/interagency-coordination-gr...
    1. Silva O.N., de La Fuente-Núñez C., Haney E.F., Fensterseifer I.C., Ribeiro S.M., Porto W.F., Brown P., Faria-Junior C., Rezende T.M., Moreno S.E., et al. An Anti-Infective Synthetic Peptide with Dual Antimicrobial and Immunomodulatory Activities. Sci. Rep. 2016;6:35465. doi: 10.1038/srep35465. - DOI - PMC - PubMed
    1. Rosén J., Gottfries J., Muresan S., Backlund A., Oprea T.I. Novel Chemical Space Exploration via Natural Products. J. Med. Chem. 2009;52:1953–1962. - PMC - PubMed
    1. Millero F.J. Chemical Oceanography. 4th ed. CRC Press Taylor & Francis Group; Boca Raton, FL, USA: 2013. Descriptive Oceanography.

LinkOut - more resources